Next Science Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 5

  • Investments
  • 1

Next Science General Information

Description

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.

Contact Information

Website
investors.nextscience.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 10550 Deerwood Park Boulevard
  • Suite 300
  • Jacksonville, FL 32256
  • United States
+1 (855)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 10550 Deerwood Park Boulevard
  • Suite 300
  • Jacksonville, FL 32256
  • United States
+1 (855)

Next Science Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Next Science Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Next Science‘s full profile, request access.

Request a free trial

Next Science Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Next Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018005702-A1 Antimicrobial compositions and methods employing same Inactive 30-Jun-2016
WO-2017027418-A1 Antimicrobial composition having efficacy against endospores Inactive 07-Aug-2015
WO-2017069820-A2 Antimicrobial composition having efficacy against endospores Inactive 17-Jul-2015
WO-2017069820-A3 Antimicrobial composition having efficacy against endospores Inactive 17-Jul-2015
WO-2014179754-A2 High osmolarity antimicrobial composition containing one or more organic solvents Inactive 02-May-2013 A01N25/02
To view Next Science’s complete patent history, request access »

Next Science Investments (1)

Next Science’s most recent deal was a PIPE with HLB Therapeutics for . The deal was made on 16-Nov-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
HLB Therapeutics 16-Nov-2021 PIPE Drug Discovery
To view Next Science’s complete investments history, request access »

Next Science Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Next Science (Goodwill)

Next Science FAQs

  • When was Next Science founded?

    Next Science was founded in 2016.

  • Where is Next Science headquartered?

    Next Science is headquartered in Jacksonville, FL.

  • What industry is Next Science in?

    Next Science’s primary industry is Biotechnology.

  • Is Next Science a private or public company?

    Next Science is a Private company.

  • What is the current valuation of Next Science?

    The current valuation of Next Science is .

  • What is Next Science’s current revenue?

    The current revenue for Next Science is .

  • How much funding has Next Science raised over time?

    Next Science has raised $58M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process